Your browser doesn't support javascript.
loading
Technical note: Optimization functions for re-irradiation treatment planning.
Ödén, Jakob; Eriksson, Kjell; Svensson, Stina; Lilley, John; Thompson, Christopher; Pagett, Christopher; Appelt, Ane; Murray, Louise; Bokrantz, Rasmus.
Afiliação
  • Ödén J; RaySeach Laboratories AB, Stockholm, Sweden.
  • Eriksson K; RaySeach Laboratories AB, Stockholm, Sweden.
  • Svensson S; RaySeach Laboratories AB, Stockholm, Sweden.
  • Lilley J; Department of Medical Physics, Leeds Cancer Centre, St. James' University Hospital, Leeds, UK.
  • Thompson C; Department of Medical Physics, Leeds Cancer Centre, St. James' University Hospital, Leeds, UK.
  • Pagett C; Department of Medical Physics, Leeds Cancer Centre, St. James' University Hospital, Leeds, UK.
  • Appelt A; Department of Medical Physics, Leeds Cancer Centre, St. James' University Hospital, Leeds, UK.
  • Murray L; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
  • Bokrantz R; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Med Phys ; 51(1): 476-484, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37921262
ABSTRACT

BACKGROUND:

Although re-irradiation is increasingly used in clinical practice, almost no dedicated planning software exists.

PURPOSE:

Standard dose-based optimization functions were adjusted for re-irradiation planning using accumulated equivalent dose in 2-Gy fractions (EQD2) with rigid or deformable dose mapping, tissue-specific α/ß, treatment-specific recovery coefficients, and voxelwise adjusted EQD2 penalization levels based on the estimated previously delivered EQD2 (EQD2deliv ).

METHODS:

To demonstrate proof-of-concept, 35 Gy in 5 fractions was planned to a fictitious spherical relapse planning target volume (PTV) in three separate locations following previous prostate treatment on a virtual human phantom. The PTV locations represented one repeated irradiation scenario and two re-irradiation scenarios. For each scenario, three re-planning strategies with identical PTV dose-functions but various organ at risk (OAR) EQD2-functions was used 1) reRTregular Regular functions with fixed EQD2 penalization levels larger than EQD2deliv for all OAR voxels. 2) reRTreduce As reRTregular , but with lower fixed EQD2 penalization levels aiming to reduce OAR EQD2. 3) reRTvoxelwise As reRTregular and reRTreduce , but with voxelwise adjusted EQD2 penalization levels based on EQD2deliv . PTV near-minimum and near-maximum dose (D98% /D2% ), homogeneity index (HI), conformity index (CI) and accumulated OAR EQD2 (α/ß = 3 Gy) were evaluated.

RESULTS:

For the repeated irradiation scenario, all strategies resulted in similar dose distributions. For the re-irradiation scenarios, reRTreduce and reRTvoxelwise reduced accumulated average and near-maximum EQD2 by ˜1-10 Gy for all relevant OARs compared to reRTregular . The reduced OAR doses for reRTreduce came at the cost of distorted dose distributions with D98% = 92.3%, HI = 12.0%, CI = 73.7% and normal tissue hot spots ≥150% for the most complex scenario, while reRTregular (D98% = 98.1%, HI = 3.2%, CI = 94.2%) and reRTvoxelwise (D98%  = 96.9%, HI = 6.1%, CI = 93.7%) fulfilled PTV coverage without hot spots.

CONCLUSIONS:

The proposed re-irradiation-specific EQD2-based optimization functions introduce novel planning possibilities with flexible options to guide the trade-off between target coverage and OAR sparing with voxelwise adapted penalization levels based on EQD2deliv .
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radioterapia de Intensidade Modulada / Reirradiação Limite: Humans / Male Idioma: En Revista: Med Phys Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radioterapia de Intensidade Modulada / Reirradiação Limite: Humans / Male Idioma: En Revista: Med Phys Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suécia